Could a single cell infusion free liver transplant patients from lifelong drugs?

NCT ID NCT03164265

First seen Oct 01, 2025 · Last updated May 13, 2026 · Updated 30 times

Summary

This study tested whether giving liver transplant patients a special immune cell infusion before surgery could help them safely stop taking anti-rejection drugs. Sixteen low-risk patients received the infusion and were slowly weaned off their medications over a year if they met certain criteria. The goal was to see if the body could accept the new liver without long-term drugs, but patients who succeeded still needed monitoring for three years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVING DONOR LIVER TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UPMC

    Pittsburgh, Pennsylvania, 15261, United States

Conditions

Explore the condition pages connected to this study.